Bristol Myers Squibb to present data highlighting progress in transforming treatment for patients with cancer and blood disorders at ASCO and EHA 2022

Evotec and Almirall agree multi-target alliance for medical dermatology

Astellas announces EVRENZO (roxadustat) Phase 3 clinical trial data

SwanBio Therapeutics Raises USD 56m in Series B Financing to Advance Novel Gene Therapies for Neurological Conditions

Qlaris Bio Reports Phase 2 Clinical Trial Results Demonstrating Favorable Safety and Tolerability Profile and Positive Efficacy Signal for QLS-101

First Patient Dosed in the DANCE Trial, a Phase 1/2 Study Evaluating APT Phage Bank in Diabetic Foot Osteomyelitis

C2N Diagnostics Introduces P-tau Multi-Analyte Assay for Research Use Only to Advance Alzheimer's Disease and Brain Health Field

Autobahn Therapeutics Posts Emerging Preclinical Data Demonstrating Ability of CNS-Delivered Thyromimetics to Promote Remyelination

Anji Pharma Completes Patient Enrollment in Phase 2 Study of Pradigastat in Functional Constipation

Regencell Bioscience Posts Additional EARTH Efficacy Trial Results Corroborating Effectiveness of its Investigational Liquid-Formula RGC-COV19 in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-Day Treatment Period

epocrates Launches Long COVID-19 Tool and Incorporates Late-Breaking Updates to an Expanding Library of Clinical Decision Support Guidelines

Humanetics Expands Long-Haul COVID-19 Trial

Ono Pharmaceutical's Opdivo(R) intravenous infusion in combination with cabozantinib gains Taiwan approval for the treatment of previously untreated or advanced renal cell carcinoma

Sunvera Group Forms New Partnership with William S. Goldstein, MD PC Laser Eye Care Center

Osivax Enters Research Collaboration with the NIAID for the Evaluation of Combination Approach to Broad-Spectrum Influenza Vaccines